Flu Vaccines Archives - Page 3 of 3

Seqirus Wins Approval for Flu Vaccine for Adults 65 and Older

510(k) Clearance, Adults, Adults 65 and Older, Approvals, FDA, FDA/Regulatory, First-In-Class, Flu Vaccines, Influenza, Seasonal Influenza, U.S. Centers for Disease Control and Prevention

Seqirus snagged U.S. FDA approval for Fluad Quadrivalent, the first quadrivalent adjuvanted influenza vaccine developed to help protect adults 65 years and older against seasonal influenza.

Genentech’s Xofluza Approved for People at High Risk of Developing Flu-Related Complications

Approvals, Clinical Data, Clinical Studies, FDA, FDA/Regulatory, First-In-Class, Flu Vaccines, Influenza, New Indications

Genentech’s flu medication Xofluza won a new indication for the treatment of acute, uncomplicated influenza in people 12 years of age and older who have been symptomatic for less than 48 hours and are at high risk of flu-related complications.

Trump signs order aimed at development of better flu vaccines

Department of Health and Human Services (HHS), Executive Orders, Flu Vaccines, Manufacturing, Pandemic Flu Outbreak, R&D, Universal Vaccines

U.S. President Donald Trump signed an executive order aimed at spurring the development of better vaccines to protect against seasonal influenza as well as a potential pandemic flu outbreak.